Reuters logo
BRIEF-Opiant Pharma, Titan Pharmac to explore new treatments for opioid abuse
October 2, 2017 / 11:10 AM / 3 months ago

BRIEF-Opiant Pharma, Titan Pharmac to explore new treatments for opioid abuse

Oct 2 (Reuters) - Opiant Pharmaceuticals Inc

* Opiant Pharmaceuticals and Titan Pharmaceuticals collaborate to explore a new approach to opioid use disorder treatment

* Opiant Pharma - co, Titan will conduct feasibility assessment of a subcutaneous implant using titan’s proprietary proneura sustained release technology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below